Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales23.5622.11 7 OPM %23.4719.13 - PBDT5.173.94 31 PBT5.013.75 34 NP5.053.68 37 Powered by Capital Market - Live News

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live News

Indo US Bio-Tech announced that the Board of Directors of the Company at its meeting held on 21 November 2024, has recommended a Interim dividend of Rs.0.25 per share (i.e.2.5%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales22.1715.81 40 OPM %23.1416.45 - PBDT4.632.19 111 PBT4.451.98 125 NP4.361.67 161 Powered by Capital Market - Live News

Indo US Bio-Tech has revised the meeting of the Board of Directors which was scheduled to be held on 16 November 2024. The meeting will now be held on 21 November 2024.Powered by Capital Market - Live News